Windtree Therapeutics Ownership 2024 | Who Owns Windtree Therapeutics Now?
Institutional Ownership
0.00%
Insider Ownership
4.01%
Institutional Holders
1.00
Windtree Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
PARALLEL ADVISORS, LLC | - | - | - | -1 | -100.00% | - | Mar 31, 2024 |
Windtree Therapeutics's largest institutional shareholder is PARALLEL ADVISORS, LLC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
PARALLEL ADVISORS, LLC | - | - | - | -1 | -100.00% | - | Mar 31, 2024 |
The largest Windtree Therapeutics shareholder by % of total assets is PARALLEL ADVISORS, LLC. The company owns 0.00 shares of Windtree Therapeutics (WINT), representing 0.00% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
PARALLEL ADVISORS, LLC | - | - | - | -1 | -100.00% | - | Mar 31, 2024 |
As of Mar 31 2024, Windtree Therapeutics's largest institutional buyer is PARALLEL ADVISORS, LLC. The company purchased -1.00 stocks of WINT, valued at -.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
PARALLEL ADVISORS, LLC | - | - | - | -1 | -100.00% | - | Mar 31, 2024 |
As of Mar 31 2024, Windtree Therapeutics's biggest institutional seller is PARALLEL ADVISORS, LLC. The company sold -1.00 shares of WINT, valued at -.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
PARALLEL ADVISORS, LLC | - | - | - | -1 | -100.00% | - | Mar 31, 2024 |
Windtree Therapeutics's largest sold out institutional shareholder by shares sold is PARALLEL ADVISORS, LLC, sold -1.00 shares, valued at -, as of undefined.
Windtree Therapeutics Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
FIDELITY CONCORD STREET TRUST | 0.00% | 156,676 | - | - | Feb 29, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 168,233 | - | - | Mar 31, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 41,640 | -41,640 | -50.00% | Mar 31, 2024 |
NORTHERN FUNDS | 0.00% | 14,087 | - | - | Mar 28, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 14,159 | - | - | Feb 29, 2024 |
Blackstone Alternative Investment Funds | 0.00% | 1,400 | - | - | Mar 31, 2023 |
EQ ADVISORS TRUST | 0.00% | 4,060 | - | - | Mar 31, 2024 |
iSHARES TRUST | 0.00% | 44,600 | - | - | Mar 31, 2024 |
Windtree Therapeutics's largest mutual fund holder by % of total assets is "FIDELITY CONCORD STREET TRUST", owning 156.68K shares, compromising 0.00% of its total assets.
Windtree Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
31 Dec, 23 | 1 | - |
30 Sep, 23 | 1 | - |
30 Jun, 23 | 1 | -50.00% |
31 Mar, 23 | 2 | -92.00% |
31 Dec, 22 | 25 | 31.58% |
30 Sep, 22 | 19 | 5.56% |
30 Jun, 22 | 18 | -14.29% |
31 Mar, 22 | 21 | -4.55% |
31 Dec, 21 | 22 | 29.41% |
30 Sep, 21 | 17 | -29.17% |
30 Jun, 21 | 24 | 60.00% |
31 Mar, 21 | 15 | 36.36% |
31 Dec, 20 | 11 | 22.22% |
30 Sep, 20 | 9 | 50.00% |
30 Jun, 20 | 6 | - |
As of 31 Dec 23, 1 institutions are holding Windtree Therapeutics's shares, representing an increase of 0.00% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
31 Dec, 23 | 1 | - |
30 Sep, 23 | 1 | - |
30 Jun, 23 | 1 | -83.33% |
31 Mar, 23 | 6 | -100.00% |
31 Dec, 22 | 1,588,861 | -7.54% |
30 Sep, 22 | 1,718,364 | 7.63% |
30 Jun, 22 | 1,596,488 | 3.85% |
31 Mar, 22 | 1,537,340 | -9.97% |
31 Dec, 21 | 1,707,521 | 16.65% |
30 Sep, 21 | 1,463,815 | -14.98% |
30 Jun, 21 | 1,721,779 | 55.22% |
31 Mar, 21 | 1,109,251 | 56.46% |
31 Dec, 20 | 708,987 | -2.51% |
30 Sep, 20 | 727,226 | 207.71% |
30 Jun, 20 | 236,335 | - |
Windtree Therapeutics (WINT) has 1.00 shares outstanding as of 31 Dec 23, up 0.00% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
31 Dec, 23 | - | - |
30 Sep, 23 | - | 214100.00% |
30 Jun, 23 | 0.00% | 23814.29% |
31 Mar, 23 | 0.00% | 0.00% |
31 Dec, 22 | 4.27% | 14.00% |
30 Sep, 22 | 5.52% | 18.46% |
30 Jun, 22 | 5.47% | 18.52% |
31 Mar, 22 | 5.43% | 11.41% |
31 Dec, 21 | 6.90% | 19.72% |
30 Sep, 21 | 5.91% | 4.89% |
30 Jun, 21 | 11.00% | 21.90% |
31 Mar, 21 | 7.09% | 34.55% |
31 Dec, 20 | 4.53% | 20.99% |
30 Sep, 20 | 4.65% | 203.82% |
30 Jun, 20 | 1.51% | - |
As of 31 Dec 23, Windtree Therapeutics is held by 0.00% institutional shareholders, representing a 0.00% growth compared to 30 Sep 23.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
31 Dec, 23 | - | - |
30 Sep, 23 | - | - |
30 Jun, 23 | - | - |
31 Mar, 23 | - | -100.00% |
31 Dec, 22 | 14 | 55.56% |
30 Sep, 22 | 9 | -10.00% |
30 Jun, 22 | 10 | -23.08% |
31 Mar, 22 | 13 | 44.44% |
31 Dec, 21 | 9 | - |
30 Sep, 21 | 9 | -52.63% |
30 Jun, 21 | 19 | 72.73% |
31 Mar, 21 | 11 | 175.00% |
31 Dec, 20 | 4 | -20.00% |
30 Sep, 20 | 5 | -16.67% |
30 Jun, 20 | 6 | - |
- institutional shareholders have increased their position in WINT stock as of 31 Dec 23 compared to - in the previous quarter (a 0.00% increase).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
31 Dec, 23 | - | - |
30 Sep, 23 | - | - |
30 Jun, 23 | - | -100.00% |
31 Mar, 23 | 2 | -50.00% |
31 Dec, 22 | 4 | - |
30 Sep, 22 | 4 | 100.00% |
30 Jun, 22 | 2 | -50.00% |
31 Mar, 22 | 4 | 33.33% |
31 Dec, 21 | 3 | - |
30 Sep, 21 | 3 | 200.00% |
30 Jun, 21 | 1 | - |
31 Mar, 21 | 1 | -66.67% |
31 Dec, 20 | 3 | 200.00% |
30 Sep, 20 | 1 | - |
30 Jun, 20 | - | - |
- institutional shareholders have reduced their position in WINT stock as of 31 Dec 23 compared to - in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
31 Dec, 23 | 1 | - | 1 | - | - | - | - | - | - | - |
30 Sep, 23 | 1 | - | 1 | - | - | 214100.00% | - | - | - | - |
30 Jun, 23 | 1 | -50.00% | 1 | -83.33% | 0.00% | 23814.29% | - | - | - | -100.00% |
31 Mar, 23 | 2 | -92.00% | 6 | -100.00% | 0.00% | 0.00% | - | -100.00% | 2 | -50.00% |
31 Dec, 22 | 25 | 31.58% | 1,588,861 | -7.54% | 4.27% | 14.00% | 14 | 55.56% | 4 | - |
30 Sep, 22 | 19 | 5.56% | 1,718,364 | 7.63% | 5.52% | 18.46% | 9 | -10.00% | 4 | 100.00% |
30 Jun, 22 | 18 | -14.29% | 1,596,488 | 3.85% | 5.47% | 18.52% | 10 | -23.08% | 2 | -50.00% |
31 Mar, 22 | 21 | -4.55% | 1,537,340 | -9.97% | 5.43% | 11.41% | 13 | 44.44% | 4 | 33.33% |
31 Dec, 21 | 22 | 29.41% | 1,707,521 | 16.65% | 6.90% | 19.72% | 9 | - | 3 | - |
30 Sep, 21 | 17 | -29.17% | 1,463,815 | -14.98% | 5.91% | 4.89% | 9 | -52.63% | 3 | 200.00% |
30 Jun, 21 | 24 | 60.00% | 1,721,779 | 55.22% | 11.00% | 21.90% | 19 | 72.73% | 1 | - |
31 Mar, 21 | 15 | 36.36% | 1,109,251 | 56.46% | 7.09% | 34.55% | 11 | 175.00% | 1 | -66.67% |
31 Dec, 20 | 11 | 22.22% | 708,987 | -2.51% | 4.53% | 20.99% | 4 | -20.00% | 3 | 200.00% |
30 Sep, 20 | 9 | 50.00% | 727,226 | 207.71% | 4.65% | 203.82% | 5 | -16.67% | 1 | - |
30 Jun, 20 | 6 | - | 236,335 | - | 1.51% | - | 6 | - | - | - |
Windtree Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Windtree Therapeutics's stock was made by McAndrew Jamie on Sep 05 2023, selling - shares at - per share (valued at -). The last insider buy of WINT was made by Fraser Craig on Sep 28 2023, buying 2,500 shares at $1.02 per share (worth $2.55K).
Windtree Therapeutics Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q3 2024 | 4 | - | - |
Q3 2023 | 16 | 8 | 200.00% |
Q2 2023 | 2 | - | - |
Q1 2023 | 3 | 9 | 33.33% |
Q3 2022 | 3 | - | - |
Q2 2022 | 7 | - | - |
Q1 2022 | 14 | - | - |
Q4 2021 | 6 | 1 | 600.00% |
Q3 2021 | 1 | - | - |
Q2 2021 | 9 | - | - |
Q1 2021 | 22 | - | - |
Q4 2020 | 6 | - | - |
Q3 2020 | 2 | - | - |
Q2 2020 | 27 | 6 | 450.00% |
Q1 2020 | 8 | - | - |
Q4 2019 | 10 | - | - |
Q2 2019 | 6 | - | - |
Q1 2019 | 8 | 12 | 66.67% |
Q4 2018 | 23 | 18 | 127.78% |
Q2 2018 | 2 | 1 | 200.00% |
4 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Windtree Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q3 2024 | - | - | - |
Q3 2023 | 2 | - | - |
Q2 2023 | 2 | - | - |
Q1 2023 | - | - | - |
Q3 2022 | 3 | - | - |
Q2 2022 | 2 | - | - |
Q1 2022 | 3 | - | - |
Q4 2021 | 6 | 1 | 600.00% |
Q3 2021 | - | - | - |
Q2 2021 | 7 | - | - |
Q1 2021 | 8 | - | - |
Q4 2020 | 6 | - | - |
Q3 2020 | - | - | - |
Q2 2020 | 27 | - | - |
Q1 2020 | 8 | - | - |
Q4 2019 | 9 | - | - |
Q2 2019 | - | - | - |
Q1 2019 | - | - | - |
Q4 2018 | 7 | - | - |
Q2 2018 | 2 | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Windtree Therapeutics's stocks.
WINT Ownership FAQ
Who Owns Windtree Therapeutics?
Windtree Therapeutics is owned by institutional shareholders (0%), insiders (4.01%), and public (0%). The largest institutional shareholder of Windtree Therapeutics is PARALLEL ADVISORS, LLC (0% of total shares) and the top mutual fund owner is FIDELITY CONCORD STREET TRUST (0.00% of total shares).
Who are the major institutional shareholders of Windtree Therapeutics?
Windtree Therapeutics's major institutional shareholders are PARALLEL ADVISORS, LLC. The top five shareholders own together 0% of the company's share outstanding.
How many Windtree Therapeutics shareholders are there?
As of Dec 2023, there are 1 institutional shareholders of Windtree Therapeutics.
What percentage of Windtree Therapeutics is owned by PARALLEL ADVISORS, LLC?
PARALLEL ADVISORS, LLC owns 0 shares of Windtree Therapeutics, representing 0% of the company's total shares outstanding, valued at $0 (as of Mar 2024).